Thoracic oncology

Should CT-guided biopsy for suspected lung cancer be delayed pending PET/CT results?
Paul Griffiths, Joanne Heaton, Sarah Claxton

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4673; DOI: 10.1183/13993003.congress-2016.PA4673
Pemetrexed in maintenance therapy of 164 patients with advanced non-small-cell lung cancer (NSCLC)
Jana Skricková, Zbynek Bortlicek, Karel Hejduk, Milos Pesek, Vitezslav Kolek, Marcela Tomiskova, Ivona Grygarkova, Leona Koubkova, Marketa Cernovska, Jaromir Roubec, Frantisek Salajka, Milada Zemanova, Helena Coupkova, Monika Satankova, Milosalav Marel

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4839; DOI: 10.1183/13993003.congress-2016.PA4839
Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients
Chai Chee Shee, Liam Chong Kin, Pang Yong Kek, Kow Keng Siong, Poh Mau Ern, Wong Chee Kuan, Tan Jiunn Liang

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4840; DOI: 10.1183/13993003.congress-2016.PA4840
Progression vs. pseudo progression in the treatment of squamous NSCLC with nivolumab
Stefan Rudiger, Cornelia Kropf-Sanchen, Gerlinde Schmidtke-Schrezenmeier, Marta Aksentiy, Katja Hoss, Wolfgang Rottbauer

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4845; DOI: 10.1183/13993003.congress-2016.PA4845
Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC)
Emma Denneny, Sarah Clarke, Ravi Ragatha, Samir Naik, Peter Russell, Nick Panagiotopoulos, David Lawrence, Ugo Ekeowa

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4849; DOI: 10.1183/13993003.congress-2016.PA4849
Checkpointinhibition in lung cancer – How to distinguish pseudoprogression from progressive disease
Achim Rittmeyer, Birgit Zwerger, Reinhardt Christian, Josef Rüschoff, Hans-Ulrich Schildhaus, Stefan Andreas

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4844; DOI: 10.1183/13993003.congress-2016.PA4844
Lung cancer revisited – CT scan and bronchoscopy concordance after treatment
Cláudia Sofia Vaz Guerreiro, Jorge Dionísio, José Duro da Costa

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4851; DOI: 10.1183/13993003.congress-2016.PA4851
Management of residual pleural space and persistent airleak after major lung resection
Kalliopi Athanassiadi, Ioannis Alevizakis, Nikolaos Papakonstantinou, Stamatios Kakaris

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4848; DOI: 10.1183/13993003.congress-2016.PA4848
Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy?
Berna Kömürcüoglu, Yelda Vatansever, Esra Korkmaz, Aysen Evkan, Enver Yalniz

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4843; DOI: 10.1183/13993003.congress-2016.PA4843
LATE-BREAKING ABSTRACT: Poor outcome following lung transplantation in CF patients infected with mycobacterium abscessus appears to be associated with two genetic clusters of mycobacterium abscessus subspecies abscessus
Ema Kavaliunaite, Kathryn A. Harris, Paul Aurora, Garth Dixon, Delane Shingadia, Nagarajan Muthialu, Helen Spencer

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4872; DOI: 10.1183/13993003.congress-2016.PA4872

Main menu

User menu

Search

Thoracic oncology

Pages